ZDHHC3 and breast cancer: Biochemically, BC induces lysosomal degradation of programmed cell death ligand-1 (PD-L1) to enhance T cell-mediated antitumor immunity by targeting DHHC3 (Figure 3) [8] and inhibits growth and biofilm formation in Pseudomonas aeruginosa [93].